Florida Senate - 2022                                    SB 1136
       
       
        
       By Senator Jones
       
       
       
       
       
       35-01291-22                                           20221136__
    1                        A bill to be entitled                      
    2         An act relating to at-home drug deactivation and
    3         disposal systems; creating s. 381.888, F.S.; defining
    4         terms; requiring the Department of Health, in
    5         coordination with the Board of Pharmacy, to establish
    6         and administer the At-home Drug Deactivation and
    7         Disposal System Program for a specified purpose;
    8         providing requirements for the at-home drug
    9         deactivation and disposal systems; requiring the
   10         department, in coordination with the board, to develop
   11         relevant educational materials and a plan for
   12         distribution of the at-home drug deactivation and
   13         disposal systems and educational materials; requiring
   14         the department, in consultation with the board, to
   15         adopt rules; providing an effective date.
   16          
   17  Be It Enacted by the Legislature of the State of Florida:
   18  
   19         Section 1. Section 381.888, Florida Statutes, is created to
   20  read:
   21         381.888 At-home Drug Deactivation and Disposal System
   22  Program.—
   23         (1) DEFINITIONS.—As used in this section, the term:
   24         (a) “Board” means the Board of Pharmacy.
   25         (b) “Department” means the Department of Health.
   26         (c) “Nonretrievable” has the same meaning as in 21 C.F.R.
   27  s. 1300.05(b), as that definition exists on the effective date
   28  of this act.
   29         (d) “Pharmacy” has the same meaning as in s. 465.003(11).
   30         (e) “Program” means the At-home Drug Deactivation and
   31  Disposal System Program.
   32         (2) PROGRAM ESTABLISHED.—
   33         (a) The department, in coordination with the board, shall
   34  establish and administer the At-home Drug Deactivation and
   35  Disposal System Program for the purpose of identifying and
   36  distributing suitable at-home drug deactivation and disposal
   37  systems that pharmacies must co-dispense with each opioid
   38  prescription. An at-home drug deactivation and disposal system
   39  must be capable of all of the following:
   40         1. Safely disposing of an opioid drug prescribed pursuant
   41  to s. 456.44(5)(a) for the treatment of acute pain.
   42         2. Permanently rendering the active pharmaceutical
   43  ingredient nonretrievable, nonusable, and environmentally safe
   44  for disposal.
   45         (b) The department, in coordination with the board, shall
   46  develop relevant educational materials and a plan for
   47  distribution of the at-home drug deactivation and disposal
   48  systems and educational materials to pharmacies in this state.
   49         (3) RULEMAKING AUTHORITY.—The department, in consultation
   50  with the board, shall adopt rules to administer the program.
   51         Section 2. This act shall take effect July 1, 2022.